Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

639 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Unrelated cord blood transplantation vs related transplantation with HLA 1-antigen mismatch in the graft-versus-host direction.
Kanda J, Ichinohe T, Kato S, Uchida N, Terakura S, Fukuda T, Hidaka M, Ueda Y, Kondo T, Taniguchi S, Takahashi S, Nagamura-Inoue T, Tanaka J, Atsuta Y, Miyamura K, Kanda Y; Donor/Source Working Group and HLA Working Group of the Japan Society for Hematopoietic Cell Transplantation. Kanda J, et al. Among authors: ichinohe t. Leukemia. 2013 Feb;27(2):286-94. doi: 10.1038/leu.2012.203. Epub 2012 Jul 18. Leukemia. 2013. PMID: 22806066
Changes in the clinical impact of high-risk human leukocyte antigen allele mismatch combinations on the outcome of unrelated bone marrow transplantation.
Kanda Y, Kanda J, Atsuta Y, Fuji S, Maeda Y, Ichinohe T, Takanashi M, Ohashi K, Fukuda T, Miyamura K, Mori T, Sao H, Kobayashi N, Iwato K, Sawada A, Mori S; HLA working group of the Japan Society for Hematopoietic Cell Transplantation. Kanda Y, et al. Among authors: ichinohe t. Biol Blood Marrow Transplant. 2014 Apr;20(4):526-35. doi: 10.1016/j.bbmt.2014.01.003. Epub 2014 Jan 10. Biol Blood Marrow Transplant. 2014. PMID: 24417871 Free article.
Impact of graft-versus-host disease on outcomes after unrelated cord blood transplantation.
Kanda J, Morishima Y, Terakura S, Wake A, Uchida N, Takahashi S, Ono Y, Onishi Y, Kanamori H, Aotsuka N, Ozawa Y, Ogawa H, Sakura T, Ohashi K, Ichinohe T, Kato K, Atsuta Y, Teshima T, Murata M. Kanda J, et al. Among authors: ichinohe t. Leukemia. 2017 Mar;31(3):663-668. doi: 10.1038/leu.2016.288. Epub 2016 Oct 17. Leukemia. 2017. PMID: 27748373
Impact of the presence of HLA 1-locus mismatch and the use of low-dose antithymocyte globulin in unrelated bone marrow transplantation.
Kawamura K, Kanda J, Fuji S, Murata M, Ikegame K, Yoshioka K, Fukuda T, Ozawa Y, Uchida N, Iwato K, Sakura T, Hidaka M, Hashimoto H, Ichinohe T, Atsuta Y, Kanda Y. Kawamura K, et al. Among authors: ichinohe t. Bone Marrow Transplant. 2017 Oct;52(10):1390-1398. doi: 10.1038/bmt.2017.153. Epub 2017 Jul 17. Bone Marrow Transplant. 2017. PMID: 28714944 Clinical Trial.
Impact of HLA allele mismatch on the clinical outcome in serologically matched related hematopoietic SCT.
Fuji S, Kanda J, Kato S, Ikegame K, Morishima S, Miyamoto T, Hidaka M, Kubo K, Miyamura K, Ohashi K, Kobayashi H, Maesako Y, Adachi S, Ichinohe T, Atsuta Y, Kanda Y; HLA Working Group of Japan Society for Hematopoietic Cell Transplantation. Fuji S, et al. Among authors: ichinohe t. Bone Marrow Transplant. 2014 Sep;49(9):1187-92. doi: 10.1038/bmt.2014.141. Epub 2014 Jul 7. Bone Marrow Transplant. 2014. PMID: 25000457
Impact of conditioning intensity and TBI on acute GVHD after hematopoietic cell transplantation.
Nakasone H, Fukuda T, Kanda J, Mori T, Yano S, Kobayashi T, Miyamura K, Eto T, Kanamori H, Iwato K, Uchida N, Mori S, Nagamura-Inoue T, Ichinohe T, Atsuta Y, Teshima T, Murata M; GVHD working group of the Japan Society of Hematopoietic Cell Transplantation. Nakasone H, et al. Among authors: ichinohe t. Bone Marrow Transplant. 2015 Apr;50(4):559-65. doi: 10.1038/bmt.2014.293. Epub 2014 Dec 22. Bone Marrow Transplant. 2015. PMID: 25531281 Clinical Trial.
Donor cell-derived hematological malignancy: a survey by the Japan Society for Hematopoietic Cell Transplantation.
Kato M, Yamashita T, Suzuki R, Matsumoto K, Nishimori H, Takahashi S, Iwato K, Nakaseko C, Kondo T, Imada K, Kimura F, Ichinohe T, Hashii Y, Kato K, Atsuta Y, Taniguchi S, Fukuda T. Kato M, et al. Among authors: ichinohe t. Leukemia. 2016 Aug;30(8):1742-5. doi: 10.1038/leu.2016.23. Epub 2016 Feb 12. Leukemia. 2016. PMID: 26867671 No abstract available.
Exploratory research for optimal GvHD prophylaxis after single unit CBT in adults: short-term methotrexate reduced the incidence of severe GvHD more than mycophenolate mofetil.
Terakura S, Wake A, Inamoto Y, Murata M, Sakai R, Yamaguchi T, Takahashi S, Uchida N, Onishi Y, Ohashi K, Ozawa Y, Kanamori H, Yamaguchi H, Fukuda T, Ichinohe T, Takanashi M, Atsuta Y, Teshima T. Terakura S, et al. Among authors: ichinohe t. Bone Marrow Transplant. 2017 Mar;52(3):423-430. doi: 10.1038/bmt.2016.255. Epub 2016 Dec 12. Bone Marrow Transplant. 2017. PMID: 27941766
GvHD prophylaxis after single-unit reduced intensity conditioning cord blood transplantation in adults with acute leukemia.
Terakura S, Kuwatsuka Y, Yamasaki S, Wake A, Kanda J, Inamoto Y, Mizuta S, Yamaguchi T, Uchida N, Kouzai Y, Aotsuka N, Ogawa H, Kanamori H, Nishiwaki K, Miyakoshi S, Onizuka M, Amano I, Fukuda T, Ichinohe T, Atsuta Y, Murata M, Teshima T. Terakura S, et al. Among authors: ichinohe t. Bone Marrow Transplant. 2017 Sep;52(9):1261-1267. doi: 10.1038/bmt.2017.116. Epub 2017 Jun 12. Bone Marrow Transplant. 2017. PMID: 28604665
Early application of related SCT might improve clinical outcome in adult T-cell leukemia/lymphoma.
Fuji S, Fujiwara H, Nakano N, Wake A, Inoue Y, Fukuda T, Hidaka M, Moriuchi Y, Miyamoto T, Uike N, Taguchi J, Eto T, Tomoyose T, Kondo T, Yamanoha A, Ichinohe T, Atsuta Y, Utsunomiya A; ATL Working Group of the Japan Society for Hematopoietic Cell Transplantation. Fuji S, et al. Among authors: ichinohe t. Bone Marrow Transplant. 2016 Feb;51(2):205-11. doi: 10.1038/bmt.2015.265. Epub 2015 Nov 2. Bone Marrow Transplant. 2016. PMID: 26524263 Clinical Trial.
639 results